about
LRRK2 phosphorylates novel tau epitopes and promotes tauopathyThe Genetic Basis of Cognitive Impairment and Dementia in Parkinson's DiseaseEmerging preclinical pharmacological targets for Parkinson's diseaseGenetic Profile, Environmental Exposure, and Their Interaction in Parkinson's DiseaseThere's Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative DiseasesPotentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression.Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.More than a Rumor Spreads in Parkinson's DiseaseAlpha-synuclein and tau: teammates in neurodegeneration?Epigenetic DNA Methylation Profiling with MSRE: A Quantitative NGS Approach Using a Parkinson's Disease Test CasePathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic miceCognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease.Parkin disease: a clinicopathologic entity?Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.Roles of tau protein in health and disease.Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathiesThe pallidopyramidal syndromes: nosology, aetiology and pathogenesis.Nonmotor symptoms in LRRK2 G2019S associated Parkinson's diseaseNon-motor and motor features in LRRK2 transgenic mice.Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's diseaseReorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers.Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants.Clinical correlations with Lewy body pathology in LRRK2-related Parkinson diseaseSigma-1 receptor: a potential new target for Parkinson's disease?Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson diseaseDiversity of mitochondrial pathology in a mouse model of axonal degeneration in synucleinopathies.Autosomal dominant Parkinson's disease caused by SNCA duplications.Alpha-Synuclein Expression in Patients with Parkinson's Disease: A Clinician's Perspective.Parkin disease and the Lewy body conundrumParkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.The Synucleinopathies: Twenty Years On.Integrating pathways of Parkinson's disease in a molecular interaction map.Can parkin be a target for future treatment of Parkinson's disease?Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesisTargeting leucine-rich repeat kinase 2 in Parkinson's disease.Modeling Lewy pathology propagation in Parkinson's disease.The pathomechanisms underlying Parkinson's disease.Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.
P2860
Q24338188-1EC06C1D-6F74-4F56-8134-0ECCF092CBB7Q26744716-AC2021BA-2C43-4605-B389-2DD99D47D175Q26764724-A3F55675-2ABB-48E4-A8FF-DFDA5EE120D0Q26768278-0FDCF980-61C1-4EA1-8465-3E5D50C3EAD2Q26768635-3E6888C6-023A-4A0A-ADF5-ED42D439954AQ27301199-C6282066-305D-4DB6-A88E-76321218BE0EQ27686808-69801BA1-F250-47E5-9028-0A72629EF29AQ27686837-8DEB80C0-0395-4749-952E-DC4BA611B4B9Q28066571-CFF04900-62B6-4745-8355-1A28574A57B7Q28250508-A38C7748-C51D-4381-A9CF-33A00C4D86AEQ28393074-E352D168-9F56-4A29-8643-64AB5868A8D3Q29620597-D3CA144B-0EFF-42F0-B8E6-EC9EC8DE15C3Q30409165-CDAD1B78-3FB2-4237-894F-4F22294DFD1DQ30594306-ED4FA32E-9FC8-44F0-9A0C-41ABAC46C625Q30626337-079955AE-02FC-4615-A876-0FDBFCDE784EQ33559303-48D680D7-34DD-46DE-906E-BE0DE77FE6B5Q34078528-12DCD074-7D06-4F8A-98E2-45526B54DA32Q34336776-24234361-B97D-4F39-81E8-F63ECDD2BE7EQ34361735-8A2D8AB0-9198-49A3-9A10-E5D5C9E41274Q34922393-2B12B159-9AE6-4071-91E3-D3103CC90B98Q35013928-AC9A45E2-8D80-4B75-B6E6-F3AB59AD929BQ35106295-D5760C46-D038-4006-8A04-C40DA0D72931Q35219481-BA4EFE5D-3944-4A97-BAD7-FFF509BEEFDDQ35442728-B673D398-E94E-4D46-8807-2DED21C9D886Q35537759-58AC67AD-163E-40FC-AFCA-9ABF8E68569FQ36595145-62AC4760-197E-44CA-ABC4-A0E3D7C4BBAEQ36729178-92B80D6A-0369-4C96-96D0-60A6FFD9DE63Q36765217-A294F643-1C11-4FFF-ADFC-16FB09978615Q36976868-3701BEB3-53EF-4DE2-8FDA-D41513E31AD5Q37086050-6530D57B-C005-43E8-91C3-690F9D73A2C7Q37385032-2135D136-775E-439E-8030-BA2EA71FA715Q37692348-53B3159E-10E9-48DD-BE53-32D89A5BA92CQ37693375-1B81D63A-B81C-4CEF-8DC2-9DEBBC896523Q38119873-2136A022-B4E3-4A30-820A-F95CA8348CB1Q38127703-50009E8E-CF0C-4D28-9A34-EDDEA6E9E5A9Q38128462-8C8DEEDC-5E4C-4B11-AAA3-3579F72BCFB4Q38160939-F51557F7-2848-4355-A0CC-9101AD788813Q38164894-CF2E5C86-F3A6-4165-8485-70CD571402ABQ38182660-53488230-ED29-4040-A772-58FBEA8F1BC0Q38186783-2DE1D1A1-1B86-48B9-BF19-8EFBAB69F9C2
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The neuropathology of genetic Parkinson's disease.
@en
The neuropathology of genetic Parkinson's disease.
@nl
type
label
The neuropathology of genetic Parkinson's disease.
@en
The neuropathology of genetic Parkinson's disease.
@nl
prefLabel
The neuropathology of genetic Parkinson's disease.
@en
The neuropathology of genetic Parkinson's disease.
@nl
P2093
P2860
P356
P1433
P1476
The neuropathology of genetic Parkinson's disease.
@en
P2093
Markos Poulopoulos
Oren A Levy
Roy N Alcalay
P2860
P304
P356
10.1002/MDS.24962
P407
P577
2012-03-26T00:00:00Z